tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

MRNS Stock Latest News

Shareholders that lost money on Marinus Pharmaceuticals, Inc.(MRNS) Urged to Join Class Action – Contact Levi & Korsinsky LLP to Learn More
Class ActionShareholders that lost money on Marinus Pharmaceuticals, Inc.(MRNS) Urged to Join Class Action – Contact Levi & Korsinsky LLP to Learn More
23d ago
MRNS
Marinus:RAISE didn’t achieve statistical significance on one endpoint
PremiumThe Fly
Marinus:RAISE didn’t achieve statistical significance on one endpoint
1M ago
MRNS
Atai Life Sciences appoints Braunstein, Fischer to supervisory board
PremiumThe Fly
Atai Life Sciences appoints Braunstein, Fischer to supervisory board
2M ago
ATAI
MIRM
Marinus completes TrustTSC enrollment, granted new patent for ganaxolone
PremiumThe Fly
Marinus completes TrustTSC enrollment, granted new patent for ganaxolone
2M ago
MRNS
Marinus Pharmaceuticals reports Q1 EPS (68c), consensus (66c)
PremiumThe Fly
Marinus Pharmaceuticals reports Q1 EPS (68c), consensus (66c)
2M ago
MRNS
Marinus Pharmaceuticals price target lowered to $11 from $27 at H.C. Wainwright
PremiumThe FlyMarinus Pharmaceuticals price target lowered to $11 from $27 at H.C. Wainwright
2M ago
MRNS
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
BHVN
CRBP
Marinus Pharmaceuticals price target lowered to $10 from $25 at Truist
PremiumThe Fly
Marinus Pharmaceuticals price target lowered to $10 from $25 at Truist
3M ago
MRNS
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
BHVN
MRNS
Marinus Pharmaceuticals downgraded to Neutral from Outperform at Baird
PremiumThe Fly
Marinus Pharmaceuticals downgraded to Neutral from Outperform at Baird
3M ago
MRNS
Marinus Pharmaceuticals downgraded to Sector Perform at RBC Capital
PremiumThe Fly
Marinus Pharmaceuticals downgraded to Sector Perform at RBC Capital
3M ago
MRNS
Marinus expects Phase 3 Trust TSC trial of ZTALMY in mid-May 2024
PremiumThe Fly
Marinus expects Phase 3 Trust TSC trial of ZTALMY in mid-May 2024
3M ago
MRNS
Marinus Pharmaceuticals sees Q1 revenue $7.4M-$7.6M, consensus $9.08M
PremiumThe FlyMarinus Pharmaceuticals sees Q1 revenue $7.4M-$7.6M, consensus $9.08M
3M ago
MRNS
Marinus trial did not meet stopping criteria at the interim analysis
PremiumThe Fly
Marinus trial did not meet stopping criteria at the interim analysis
3M ago
MRNS
Marinus Comments on patent challenge by Ovid Therapeutics
PremiumThe Fly
Marinus Comments on patent challenge by Ovid Therapeutics
4M ago
MRNS
OVID
Marinus Pharmaceuticals management to meet with Jefferies
PremiumThe Fly
Marinus Pharmaceuticals management to meet with Jefferies
4M ago
MRNS
Marinus Pharmaceuticals management to meet with Jefferies
PremiumThe Fly
Marinus Pharmaceuticals management to meet with Jefferies
4M ago
MRNS
Marinus Pharmaceuticals’ ganaxolone approved by MHRA
PremiumThe Fly
Marinus Pharmaceuticals’ ganaxolone approved by MHRA
4M ago
MRNS
Marinus Pharmaceuticals sees FY24 U.S. ZTALMY revenue $32M-$34M
PremiumThe Fly
Marinus Pharmaceuticals sees FY24 U.S. ZTALMY revenue $32M-$34M
4M ago
MRNS
Marinus Pharmaceuticals reports Q4 EPS (74c), consensus (62c)
PremiumThe FlyMarinus Pharmaceuticals reports Q4 EPS (74c), consensus (62c)
4M ago
MRNS
MRNS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
MRNS Earnings this Week: How Will it Perform?
5M ago
MRNS
Marinus Pharmaceuticals Stock (NASDAQ:MRNS): This Drugmaker Boasts a Rare Treatment
PremiumStock Analysis & Ideas
Marinus Pharmaceuticals Stock (NASDAQ:MRNS): This Drugmaker Boasts a Rare Treatment
6M ago
MRNS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >